{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T07:00:54Z","timestamp":1785481254773,"version":"3.56.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,30]]},"DOI":"10.7759\/cureus.113701","type":"journal-article","created":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T06:45:43Z","timestamp":1785480343000},"source":"Crossref","is-referenced-by-count":0,"title":["Receptor Contribution Reallocation After Removal of Literature-Derived Weights: A Secondary Sensitivity Analysis of the Integrated Ki-DDD-TWAS Pipeline for Antipsychotic Lipid-Trait Prioritization"],"prefix":"10.7759","author":[{"given":"Ngo","family":"Cheung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoi-Ki","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yee-Wah","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yolanda Yuen-Ching","family":"Tsang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2011.156","article-title":"Metabolic and cardiovascular adverse effects associated with antipsychotic drugs","volume":"8","author":"De Hert M","year":"2011","unstructured":"De Hert M, Detraux J, van Winkel R, Yu W, Correll CU. Metabolic and cardiovascular adverse effects associated with antipsychotic drugs. Nat Rev Endocrinol. 2011, 8:114-26. 10.1038\/nrendo.2011.156","journal-title":"Nat Rev Endocrinol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/wps.20252","article-title":"Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta-analysis","volume":"14","author":"Vancampfort D","year":"2015","unstructured":"Vancampfort D, Stubbs B, Mitchell AJ, et al.. Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta-analysis. World Psychiatry. 2015, 14:339-47. 10.1002\/wps.20252","journal-title":"World Psychiatry"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(19)30416-X","article-title":"Comparative effects of 18 antipsychotics on metabolic function in patients with schizophrenia, predictors of metabolic dysregulation, and association with psychopathology: a systematic review and network meta-analysis","volume":"7","author":"Pillinger T","year":"2020","unstructured":"Pillinger T, McCutcheon RA, Vano L, et al.. Comparative effects of 18 antipsychotics on metabolic function in patients with schizophrenia, predictors of metabolic dysregulation, and association with psychopathology: a systematic review and network meta-analysis. Lancet Psychiatry. 2020, 7:64-77. 10.1016\/S2215-0366(19)30416-X","journal-title":"Lancet Psychiatry"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/wps.21036","article-title":"Metabolic side effects in persons with schizophrenia during mid- to long-term treatment with antipsychotics: a network meta-analysis of randomized controlled trials","volume":"22","author":"Burschinski A","year":"2023","unstructured":"Burschinski A, Schneider-Thoma J, Chiocchia V, et al.. Metabolic side effects in persons with schizophrenia during mid- to long-term treatment with antipsychotics: a network meta-analysis of randomized controlled trials. World Psychiatry. 2023, 22:116-28. 10.1002\/wps.21036","journal-title":"World Psychiatry"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1192\/bjo.2024.757","article-title":"Lipid disturbances induced by psychotropic drugs: clinical and genetic predictors for early worsening of lipid levels and new-onset dyslipidaemia in Swiss psychiatric samples","volume":"10","author":"Delacr\u00e9taz A","year":"2024","unstructured":"Delacr\u00e9taz A, Sadler M, Gamma F, et al.. Lipid disturbances induced by psychotropic drugs: clinical and genetic predictors for early worsening of lipid levels and new-onset dyslipidaemia in Swiss psychiatric samples. BJPsych Open. 2024, 10:e227. 10.1192\/bjo.2024.757","journal-title":"BJPsych Open"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1300027","article-title":"H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs","volume":"28","author":"Kroeze WK","year":"2003","unstructured":"Kroeze WK, Hufeisen SJ, Popadak BA, et al.. H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs. Neuropsychopharmacology. 2003, 28:519-26. 10.1038\/sj.npp.1300027","journal-title":"Neuropsychopharmacology"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/sj.mp.4002066","article-title":"Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles","volume":"13","author":"Nasrallah HA","year":"2008","unstructured":"Nasrallah HA. Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles. Mol Psychiatry. 2008, 13:27-35. 10.1038\/sj.mp.4002066","journal-title":"Mol Psychiatry"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2009.10.010","article-title":"Metabolic side effects of antipsychotic drug treatment--pharmacological mechanisms","volume":"125","author":"Reynolds GP","year":"2010","unstructured":"Reynolds GP, Kirk SL. Metabolic side effects of antipsychotic drug treatment--pharmacological mechanisms. Pharmacol Ther. 2010, 125:169-79. 10.1016\/j.pharmthera.2009.10.010","journal-title":"Pharmacol Ther"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/nrd1346","article-title":"Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia","volume":"3","author":"Roth BL","year":"2004","unstructured":"Roth BL, Sheffler DJ, Kroeze WK. Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia. Nat Rev Drug Discov. 2004, 3:353-9. 10.1038\/nrd1346","journal-title":"Nat Rev Drug Discov"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.2133\/dmpk.20.368","article-title":"Receptor occupancy-based analysis of the contributions of various receptors to antipsychotics-induced weight gain and diabetes mellitus","volume":"20","author":"Matsui-Sakata A","year":"2005","unstructured":"Matsui-Sakata A, Ohtani H, Sawada Y. Receptor occupancy-based analysis of the contributions of various receptors to antipsychotics-induced weight gain and diabetes mellitus. Drug Metab Pharmacokinet. 2005, 20:368-78. 10.2133\/dmpk.20.368","journal-title":"Drug Metab Pharmacokinet"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-024-02433-8","article-title":"Precision medicine for psychotic disorders: objective assessment, risk prediction, and pharmacogenomics","volume":"29","author":"Hill MD","year":"2024","unstructured":"Hill MD, Gill SS, Le-Niculescu H, et al.. Precision medicine for psychotic disorders: objective assessment, risk prediction, and pharmacogenomics. Mol Psychiatry. 2024, 29:1528-49. 10.1038\/s41380-024-02433-8","journal-title":"Mol Psychiatry"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1080\/17425255.2026.2639520","article-title":"From pharmacokinetic genes to polygenic scores and multi-omic integration: advances toward precision psychiatry","volume":"22","author":"Bellanca CM","year":"2026","unstructured":"Bellanca CM, Squassina A, Manchia M, et al.. From pharmacokinetic genes to polygenic scores and multi-omic integration: advances toward precision psychiatry. Expert Opin Drug Metab Toxicol. 2026, 22:105-22. 10.1080\/17425255.2026.2639520","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3367","article-title":"A gene-based association method for mapping traits using reference transcriptome data","volume":"47","author":"Gamazon ER","year":"2015","unstructured":"Gamazon ER, Wheeler HE, Shah KP, et al.. A gene-based association method for mapping traits using reference transcriptome data. Nat Genet. 2015, 47:1091-8. 10.1038\/ng.3367","journal-title":"Nat Genet"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3506","article-title":"Integrative approaches for large-scale transcriptome-wide association studies","volume":"48","author":"Gusev A","year":"2016","unstructured":"Gusev A, Ko A, Shi H, et al.. Integrative approaches for large-scale transcriptome-wide association studies. Nat Genet. 2016, 48:245-52. 10.1038\/ng.3506","journal-title":"Nat Genet"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03621-1","article-title":"Exploring the phenotypic consequences of tissue specific gene expression variation inferred from GWAS summary statistics","volume":"9","author":"Barbeira AN","year":"2018","unstructured":"Barbeira AN, Dickinson SP, Bonazzola R, et al.. Exploring the phenotypic consequences of tissue specific gene expression variation inferred from GWAS summary statistics. Nat Commun. 2018, 9:1825. 10.1038\/s41467-018-03621-1","journal-title":"Nat Commun"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-019-0385-z","article-title":"Opportunities and challenges for transcriptome-wide association studies","volume":"51","author":"Wainberg M","year":"2019","unstructured":"Wainberg M, Sinnott-Armstrong N, Mancuso N, et al.. Opportunities and challenges for transcriptome-wide association studies. Nat Genet. 2019, 51:592-9. 10.1038\/s41588-019-0385-z","journal-title":"Nat Genet"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3538","article-title":"Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets","volume":"48","author":"Zhu Z","year":"2016","unstructured":"Zhu Z, Zhang F, Hu H, et al.. Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets. Nat Genet. 2016, 48:481-7. 10.1038\/ng.3538","journal-title":"Nat Genet"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-019-0367-1","article-title":"Probabilistic fine-mapping of transcriptome-wide association studies","volume":"51","author":"Mancuso N","year":"2019","unstructured":"Mancuso N, Freund MK, Johnson R, Shi H, Kichaev G, Gusev A, Pasaniuc B. Probabilistic fine-mapping of transcriptome-wide association studies. Nat Genet. 2019, 51:675-82. 10.1038\/s41588-019-0367-1","journal-title":"Nat Genet"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1004383","article-title":"Bayesian test for colocalisation between pairs of genetic association studies using summary statistics","volume":"10","author":"Giambartolomei C","year":"2014","unstructured":"Giambartolomei C, Vukcevic D, Schadt EE, Franke L, Hingorani AD, Wallace C, Plagnol V. Bayesian test for colocalisation between pairs of genetic association studies using summary statistics. PLoS Genet. 2014, 10:e1004383. 10.1371\/journal.pgen.1004383","journal-title":"PLoS Genet"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.6084\/m9.figshare.32993975.v1","article-title":"Systematic comparison of four TWAS scaling methods within an integrated Ki-DDD-TWAS pipeline for antipsychotic metabolic risk assessment [preprint]","volume":"4","author":"Cheung N","year":"2026","unstructured":"Cheung N, Cheung HK, Yu YW, Tsang YCY. Systematic comparison of four TWAS scaling methods within an integrated Ki-DDD-TWAS pipeline for antipsychotic metabolic risk assessment [preprint]. Figshare. 2026, 4:7-9. 10.6084\/m9.figshare.32993975.v1","journal-title":"Figshare"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"ATC\/DDD index 2026. (2026). Accessed. July 26, 2026: http:\/\/atcddd.fhi.no.","DOI":"10.55277\/researchhub.2zxjuwut.1"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000022","article-title":"STrengthening the REporting of Genetic Association Studies (STREGA): an extension of the STROBE statement","volume":"6","author":"Little J","year":"2009","unstructured":"Little J, Higgins JP, Ioannidis JP, et al.. STrengthening the REporting of Genetic Association Studies (STREGA): an extension of the STROBE statement. PLoS Med. 2009, 6:e22. 10.1371\/journal.pmed.1000022","journal-title":"PLoS Med"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2023-078378","article-title":"TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods","volume":"385","author":"Collins GS","year":"2024","unstructured":"Collins GS, Moons KG, Dhiman P, et al.. TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods. BMJ. 2024, 385:e078378. 10.1136\/bmj-2023-078378","journal-title":"BMJ"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-024-02447-2","article-title":"Genome-wide association study implicates lipid pathway dysfunction in antipsychotic-induced weight gain: multi-ancestry validation","volume":"29","author":"Liao Y","year":"2024","unstructured":"Liao Y, Yu H, Zhang Y, et al.. Genome-wide association study implicates lipid pathway dysfunction in antipsychotic-induced weight gain: multi-ancestry validation. Mol Psychiatry. 2024, 29:1857-68. 10.1038\/s41380-024-02447-2","journal-title":"Mol Psychiatry"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-025-03499-w","article-title":"Pharmacogenetic study of antipsychotic-induced lipid and BMI changes in Chinese schizophrenia patients: a genome-wide association study","volume":"15","author":"Wong KC","year":"2025","unstructured":"Wong KC, Leung PB, Lee BK, et al.. Pharmacogenetic study of antipsychotic-induced lipid and BMI changes in Chinese schizophrenia patients: a genome-wide association study. Transl Psychiatry. 2025, 15:295. 10.1038\/s41398-025-03499-w","journal-title":"Transl Psychiatry"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.2174\/1570159X15666170630163616","article-title":"Antipsychotic drugs: from receptor-binding profiles to metabolic side effects","volume":"16","author":"Siafis S","year":"2018","unstructured":"Siafis S, Tzachanis D, Samara M, Papazisis G. Antipsychotic drugs: from receptor-binding profiles to metabolic side effects. Curr Neuropharmacol. 2018, 16:1210-23. 10.2174\/1570159X15666170630163616","journal-title":"Curr Neuropharmacol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2017.00643","article-title":"Molecular mechanisms of antipsychotic drug-induced diabetes","volume":"11","author":"Chen J","year":"2017","unstructured":"Chen J, Huang XF, Shao R, Chen C, Deng C. Molecular mechanisms of antipsychotic drug-induced diabetes. Front Neurosci. 2017, 11:643. 10.3389\/fnins.2017.00643","journal-title":"Front Neurosci"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.54.5.1552","article-title":"Inhibitory effects of antipsychotics on carbachol-enhanced insulin secretion from perifused rat islets: role of muscarinic antagonism in antipsychotic-induced diabetes and hyperglycemia","volume":"54","author":"Johnson DE","year":"2005","unstructured":"Johnson DE, Yamazaki H, Ward KM, et al.. Inhibitory effects of antipsychotics on carbachol-enhanced insulin secretion from perifused rat islets: role of muscarinic antagonism in antipsychotic-induced diabetes and hyperglycemia. Diabetes. 2005, 54:1552-8. 10.2337\/diabetes.54.5.1552","journal-title":"Diabetes"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.3390\/ph16020154","article-title":"Selective 5-HT6 receptor ligands (agonist and antagonist) show different effects on antipsychotic drug-induced metabolic dysfunctions in rats","volume":"16","author":"Partyka A","year":"2023","unstructured":"Partyka A, G\u00f3recka K, Gdula-Argasi\u0144ska J, Wilczy\u0144ska-Zawal N, Jastrz\u0119bska-Wi\u0119sek M, Weso\u0142owska A. Selective 5-HT6 receptor ligands (agonist and antagonist) show different effects on antipsychotic drug-induced metabolic dysfunctions in rats. Pharmaceuticals (Basel). 2023, 16:32-4. 10.3390\/ph16020154","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1097\/01.jcp.0000203196.65710.2b","article-title":"Risperidone-related weight gain: genetic and nongenetic predictors","volume":"26","author":"Lane HY","year":"2006","unstructured":"Lane HY, Liu YC, Huang CL, Chang YC, Wu PL, Lu CT, Chang WH. Risperidone-related weight gain: genetic and nongenetic predictors. J Clin Psychopharmacol. 2006, 26:128-34. 10.1097\/01.jcp.0000203196.65710.2b","journal-title":"J Clin Psychopharmacol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1177\/0269881117722987","article-title":"Mechanisms underlying metabolic disturbances associated with psychosis and antipsychotic drug treatment","volume":"31","author":"Reynolds GP","year":"2017","unstructured":"Reynolds GP, McGowan OO. Mechanisms underlying metabolic disturbances associated with psychosis and antipsychotic drug treatment. J Psychopharmacol. 2017, 31:1430-6. 10.1177\/0269881117722987","journal-title":"J Psychopharmacol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/518815-receptor-contribution-reallocation-after-removal-of-literature-derived-weights-a-secondary-sensitivity-analysis-of-the-integrated-ki-ddd-twas-pipeline-for-antipsychotic-lipid-trait-prioritization","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T06:45:45Z","timestamp":1785480345000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/518815-receptor-contribution-reallocation-after-removal-of-literature-derived-weights-a-secondary-sensitivity-analysis-of-the-integrated-ki-ddd-twas-pipeline-for-antipsychotic-lipid-trait-prioritization"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,30]]},"references-count":31,"URL":"https:\/\/doi.org\/10.7759\/cureus.113701","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7,30]]}}}